Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for patients with moderate-to-severe psoriasis: a cohort study from BADBIR — Oras Alabas (2023) | RDL Network
Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for patients with moderate-to-severe psoriasis: a cohort study from BADBIR
Article 2023 en
Authors
OA
Oras Alabas
KM
K.J. Mason
ZY
Zenas Z N Yiu
Abstract
1 min read
The real-world effectiveness and persistence of acitretin, ciclosporin, FAEs and methotrexate were generally low. Previous nonbiologic systemic therapies, male sex, comorbidities and alcohol consumption were risk factors associated with treatment ineffectiveness.
K.J. Mason, S. Williams, Zenas Z N Yiu, Kathleen McElhone, Darren M. Ashcroft, C. Elise Kleyn, Zarif K. Jabbar‐Lopez, Caroline Owen, Nick J. Reynolds, Catherine Smith, Nina Wilson, Richard B. Warren, Christopher Em Griffiths
K.J. Mason, S. Williams, Zenas Z N Yiu, Kathleen McElhone, Darren M. Ashcroft, C. Elise Kleyn, Zarif K. Jabbar‐Lopez, Caroline Owen, Nick J. Reynolds, Catherine Smith, Nina Wilson, Richard B. Warren, Christopher Em Griffiths
Ireny Iskandar, Darren M. Ashcroft, Richard B. Warren, Ian M. Evans, Kathleen McElhone, Caroline Owen, A. David Burden, Catherine Smith, Nick J. Reynolds, Christopher Em Griffiths
Oras Alabas, K.J. Mason, Zenas Z N Yiu, Catherine Smith, Richard B. Warren, Christopher Em Griffiths, Juliet N. Barker, Simon Morrison, Anthony Bewley, Ian Evans, Christopher Griffiths, Shehnaz Ahmed, Brian Kirby, Elise Kleyn, Philip Laws, Philip Hampton, Oras Alabas, Kathleen McElhone, Zenas Z N Yiu, Teena Mackenzie, Tess McPherson,
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.